The RESS process was successfully applied to produce submicron particles of Paracetamol, Mefenamic acid, Nabumetone, and Tolbutamide.
The mean particle size of processed particles increases in the following order: Mefenamic acid (0.08 μm ≤ x50 ≤ 0.16 μm) < Paracetamol (0.16 μm ≤ x50 ≤ 0.34 μm) < Tolbutamide (0.34 μm ≤ x50 ≤ 0.45 μm) < Nabumetone (0.75 μm ≤ x50 ≤ 0.81 μm).
This study demonstrates that under certain temperature (333 and 353 K) and pressure (15, 20, 25 and 30 MPa) conditions RESS enables the formation of the favorable Tolbutamide polymorphic form II.
Simple static treatment with supercritical CO2 does not induce polymorphic conversion of the drugs investigated.